Observational studyAnnals of clinical and translational neurology2024

Alemtuzumab treatment for multiple sclerosis in Austria: An observational long-term outcome study.

Tobias Moser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.